Literature DB >> 22886281

Masked hypertension is prevalent in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study.

Ibrahim F Shatat1, Sherron M Jakson, Amanda E Blue, Mary A Johnson, John K Orak, Ram Kalpatthi.   

Abstract

BACKGROUND: The prevalence of hypertension and abnormal blood pressure (BP) patterns on 24-h ambulatory BP monitoring (ABPM) remains unknown in children with sickle cell disease (SCD).
METHODS: Thirty-eight asymptomatic children with sickle cell disease (SCD) (12 HbSS receiving routine care, 13 HbSC, and 13 HbSS receiving chronic transfusion therapy) underwent 24-h ABPM. Average clinic BP, demographic and biochemical characteristics were collected.
RESULTS: Median age was 13 years (range 11-16), body mass index (BMI) 19.1 kg/m(2) (range 18.2-21.1), and 50% were male. Seventeen subjects (43.6%) had ambulatory hypertension, while 4 (10.3%) were hypertensive based on their clinic BP. Mean systolic blood pressure (SBP) and diastolic blood pressure (DBP) dip were 8.3 ± 5.9% and 14.7 ± 7.6% respectively. Twenty-three subjects (59%) had impaired SBP dipping, 7 (18%) had impaired DBP dipping, and 5 (13%) had reversed dipping. Clinic and ABP classification were modestly correlated (rho = 0.38, P = 0.02).
CONCLUSION: Abnormalities in ABP measurements and patterns in children with SCD are prevalent and require more attention from heath care providers. ABPM is a valuable tool in identifying masked hypertension and abnormalities in circadian BP.

Entities:  

Mesh:

Year:  2012        PMID: 22886281     DOI: 10.1007/s00467-012-2275-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  30 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension.

Authors:  C W Belsha; T G Wells; K L McNiece; P M Seib; J K Plummer; P L Berry
Journal:  Am J Hypertens       Date:  1998-04       Impact factor: 2.689

3.  The sickle gene: a marker for blood pressure?

Authors:  L L Adams-Campbell; M U Nwankwo; F A Ukoli; T Biu
Journal:  J Natl Med Assoc       Date:  1993-05       Impact factor: 1.798

4.  Prevalence, persistence, and clinical significance of masked hypertension in youth.

Authors:  Empar Lurbe; Isabel Torro; Vicente Alvarez; Tim Nawrot; Rafael Paya; Josep Redon; Jan A Staessen
Journal:  Hypertension       Date:  2005-03-14       Impact factor: 10.190

5.  Relationships between renin, aldosterone, and 24-hour ambulatory blood pressure in obese adolescents.

Authors:  Ibrahim F Shatat; Joseph T Flynn
Journal:  Pediatr Res       Date:  2011-04       Impact factor: 3.756

6.  Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study.

Authors:  Takayoshi Ohkubo; Masahiro Kikuya; Hirohito Metoki; Kei Asayama; Taku Obara; Junichiro Hashimoto; Kazuhito Totsune; Haruhisa Hoshi; Hiroshi Satoh; Yutaka Imai
Journal:  J Am Coll Cardiol       Date:  2005-08-02       Impact factor: 24.094

7.  Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure.

Authors:  Michael R DeBaun; Sharada A Sarnaik; Mark J Rodeghier; Caterina P Minniti; Thomas H Howard; Rathi V Iyer; Baba Inusa; Paul T Telfer; Melanie Kirby-Allen; Charles T Quinn; Françoise Bernaudin; Gladstone Airewele; Gerald M Woods; Julie Ann Panepinto; Beng Fuh; Janet K Kwiatkowski; Allison A King; Melissa M Rhodes; Alexis A Thompson; Mark E Heiny; Rupa C Redding-Lallinger; Fenella J Kirkham; Hernan Sabio; Corina E Gonzalez; Suzanne L Saccente; Karen A Kalinyak; John J Strouse; Jason M Fixler; Mae O Gordon; J Phillip Miller; Michael J Noetzel; Rebecca N Ichord; James F Casella
Journal:  Blood       Date:  2011-11-17       Impact factor: 22.113

8.  Chronic transfusion therapy for children with sickle cell disease and recurrent acute chest syndrome.

Authors:  Jane Hankins; Michael Jeng; Sylvia Harris; Chin-Shang Li; Tiebin Liu; Winfred Wang
Journal:  J Pediatr Hematol Oncol       Date:  2005-03       Impact factor: 1.289

9.  Variation in cuff blood pressure in untreated outpatients with mild hypertension--implications for initiating antihypertensive treatment.

Authors:  R D Watson; R Lumb; M A Young; T J Stallard; P Davies; W A Littler
Journal:  J Hypertens       Date:  1987-04       Impact factor: 4.844

10.  Relationship between adiponectin and ambulatory blood pressure in obese adolescents.

Authors:  Ibrahim F Shatat; Katherine D Freeman; Patricia M Vuguin; Joan R Dimartino-Nardi; Joseph T Flynn
Journal:  Pediatr Res       Date:  2009-06       Impact factor: 3.756

View more
  17 in total

Review 1.  Measuring success: utility of biomarkers in sickle cell disease clinical trials and care.

Authors:  Ram Kalpatthi; Enrico M Novelli
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia.

Authors:  Jeffrey D Lebensburger; Gary R Cutter; Thomas H Howard; Paul Muntner; Daniel I Feig
Journal:  Pediatr Nephrol       Date:  2017-04-05       Impact factor: 3.714

3.  Diagnosis and management of white-coat hypertension in children and adolescents: A Midwest Pediatric Nephrology Consortium study.

Authors:  Yosuke Miyashita; Joseph T Flynn; Coral D Hanevold
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-07-23       Impact factor: 3.738

Review 4.  Ambulatory Blood Pressure Monitoring in Children and Adolescents: a Review of Recent Literature and New Guidelines.

Authors:  Ian Macumber
Journal:  Curr Hypertens Rep       Date:  2017-10-25       Impact factor: 5.369

5.  Hyperfiltration during early childhood precedes albuminuria in pediatric sickle cell nephropathy.

Authors:  Jeffrey D Lebensburger; Inmaculada Aban; Brandi Pernell; Malgorzata Kasztan; Daniel I Feig; Lee M Hilliard; David J Askenazi
Journal:  Am J Hematol       Date:  2019-01-08       Impact factor: 10.047

6.  Arterial Stiffness and Peripheral and Central Blood Pressure in Patients With Sickle Cell Disease.

Authors:  Maria Pikilidou; Maria Yavropoulou; Maria Antoniou; Eleftherios Papakonstantinou; Despoina Pantelidou; Panagiota Chalkia; Peter Nilsson; John Yovos; Pantelis Zebekakis
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-05-20       Impact factor: 3.738

7.  Blood pressure unknowns of sickle cell disease in children.

Authors:  Bonita Falkner
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-09       Impact factor: 3.738

Review 8.  Sickle cell nephropathy: insights into the pediatric population.

Authors:  Oyindamola C Adebayo; Lambertus P Van den Heuvel; Wasiu A Olowu; Elena N Levtchenko; Veerle Labarque
Journal:  Pediatr Nephrol       Date:  2021-05-29       Impact factor: 3.651

9.  Unmasking hypertension in children and adolescents with sickle/beta-thalassemia.

Authors:  Stella Stabouli; Christina Antza; Eleni Papadopoulou; Aikaterini Teli; Vasilios Kotsis; Marina Economou
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-06       Impact factor: 3.738

Review 10.  Hypertension and childhood stroke.

Authors:  Juan C Kupferman; Marc B Lande; Stella Stabouli; Dimitrios I Zafeiriou; Steven G Pavlakis
Journal:  Pediatr Nephrol       Date:  2020-04-29       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.